Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDCEO, InVitae Corporation*1,185,1173.64%2012-07-10
Steven Shak,M.D.EVP of R&D320,1160.98%2015-02-13
Joffre B. Baker,PhDChief Scientific Officer132,8460.41%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,1280.2%2016-01-01
Kimberly J. PopovitsPresident and CEO35,6910.11%2016-01-12
G. Bradley ColeCOO27,428less than 0.1%2016-01-12
Mr. Dean L. SchornoCFO24,524less than 0.1%2014-06-10
Mr. James J. VaughnChief Commercial Officer24,076less than 0.1%2016-01-07
Brook H. ByersN/A23,951less than 0.1%2010-12-09
Kathy L. HibbsSVP & General Counsel15,787less than 0.1%2014-02-15

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.2-13.536,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.8-12.3127,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.3-17.3724,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117-5.0227,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.2-5.2512,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.7-5.2524,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.16.7630,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.352459.6330,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.10.9430,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.241055.9130,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.20.9129,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.8-11.16Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.8-8.7129,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.7-12.91Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.4-12.7229,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.6-6.93Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.5-11.4121,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.9-12.976,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.4-16.95Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9999-15.76Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141-14.5421,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.7-20.19Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-21.3922,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.7-23.326,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.3-9.71Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.1-3.4122,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.5-6.81Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.4-7.6422,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.21.57312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.26.6Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.84.51Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.22.7422,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271892.93312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.13.97312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.36.48Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.50.6224,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.81.8322,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.64.71Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.410.7623,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.85.87311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27812.9322,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.5-2.01311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.30.1122,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.6-0.3215,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.71.5311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27812.9324,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.6-11.81308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-7.37Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.5-1.3518,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57414-6.02308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-9.42Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.8-16.4221,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.9-20.426,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-19.64Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.1-16.721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-11.4418,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.4-6.34308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-7.37Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.9-7.2118,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.7-17.61313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.8-19Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.3-14.5718,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-15.5321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.5-11.756,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-15.74318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.6-15.86Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-16.1721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-16.1721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.2-17.4419,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.7-21.34318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.1-19.71Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.2-17.8117,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.2-17.8117,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.3-16.6213,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-17.09323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-22.11Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.5-22.5517,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.6-23.15
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.2-23.813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.5-24.3
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-23.656,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-24.67
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.9-24.75
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.5-25.857,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19186-25.28327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452604-23.76
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-22.446,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.2-19.07
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243-19.267,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-19.91Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.1-22.8517,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9990-22.7812,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-7.37Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.5012,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.4-2.7312,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.60.04
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-1.217,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481481-2.42
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-2.152,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.5-1.28
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.1-0.8614,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.5-3.416,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-0.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-0.3214,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.70.18333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.791390Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-0.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.7-0.186,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.13.58288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.33.3536,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.73.16338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.51.72288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.22.02Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-0.07288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-0.7517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.6-2.914,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-15.99Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.3-21.16343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.4-17.7617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.2-17.7311,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-20.1414,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-17.68348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.5-12.31Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.5-20.6214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-21.052,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99175-20.58353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-19.96Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.2-8.8614,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-22.596,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-18.84358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-20.05Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-21.47Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.9-22.714,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.3-16.42363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-16.7Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-16.7Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-17.14Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.9-18.1913,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-17.78367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.5-13.86
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.5-15.8626,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.9-17.98
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-18.81Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.7-17.5117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442-7.24
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-8.04Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.2-3.7413,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.7-2.32
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.4-1.496,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.7-0.5372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.791390Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9828-0.6818,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-2.8Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-8.2213,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-7.61377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.4-7.58Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.4-7.58Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-7.61377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.1-10.5919,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-10.5Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.9-7.1813,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.7-7.71
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.1-7.71
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.1-7.71
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-6.78
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.4-6.78
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934-6.78
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.2-4.37
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-4.37
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.7-4.37
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-2.49Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.4-0.96
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-0.96
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-0.96
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-1.24382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.6-5.28
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.8-5.38
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.3-5.38
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.7-3.3720,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.8-3.3720,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.25.42
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.15.42
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.15.42
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.66.15Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.66.15Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.24.9914,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.51551.026,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.15.19Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.14.4Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.73.93382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-0.7517,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.90.917,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.21.2Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.26.76387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.81.83Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.5-2.87,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.6-1.17
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.70.47
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.2-1.17
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.37.26
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.27.13
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.87.26
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.46.6392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.7117900.29
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.70.29
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.51.61
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.22.06
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.52.06
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.82.02Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.53.73
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.54.477,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.77.13
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.57.13
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.913.52
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.225.866,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.827.71392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.621.73Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.624.567,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.233.54Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.225.867,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.120.72392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.813.71Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.210.027,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.210.027,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.95.076,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.10.65392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.21.571,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.70.187,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.62.47392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.97.2618,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.88.171,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.16.11
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.96.11
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.76.07
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.56.157,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.61.65
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.11.61
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.31.61
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.88.77392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.54.9519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.24.24Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.87.177,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.16.72Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.99.5Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.99.02Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.39.76Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.27.05Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.63.27Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.313.66Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.816.81Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.314.41Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.314.41Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.48.47Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.46.76Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.810.89Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.110.89Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.110.15Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.49.19Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.18.17Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.78.17Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.918.81Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.218.81Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.419.42Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.523.46Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.123.46Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244425.18Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.231.39Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.231.39Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.931.96Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.627.89Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.725.58Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.722.37Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.223.73Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.622.75Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514058.8Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.154.05Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.452.11Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527999.21Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.884.04Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.486.89Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.585.14Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.187.64Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.987.64Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.692.19Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.192.19Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.193.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.793.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.891.39Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.391.39Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.985.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.685.39Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.684.41Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.487.14Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.887.14Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.585.27Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.288.92Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.690.21Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.290.21Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.388.41Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2116.94Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.4112.95Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528396.4Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.056597.79Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.276.11Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.775.11Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.278.03Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.879.17Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.464.73Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.564.44Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.164.63Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538942.88Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338643.99Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.543.32Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.342.88Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.840.14Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.162.99Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.862.99Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.661.29Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.858.71Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.563.37Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.963.37Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.362.14Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.361.1Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.959.07Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.638.12Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.3910236.29Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.836.09Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.937.3Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.837.17Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.244.66Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.338.67Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.939.02Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.638.95Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.334.58Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.136.09Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.934.51Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179831.27Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.731.52Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.734.06Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.6724834.45Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.138.12Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.933.8Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.739.09Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.339.09Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.739.09Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.939.09Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.742.29Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010038.95Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.442.59Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.942.51Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.842.59Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.942.59Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.4223343.1Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.242.66Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.173.58
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.173.58
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.652.11
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.957.09
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199546.26
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.954.65
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.654.65
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.854.65
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.454.65
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.638.12
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.542.81
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.742.15
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.142.15
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.542.15
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.842.15
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.340.92
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.69.11
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.271179.97
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.843.25
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.645.27
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.629.14
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.434.9
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.434.9
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.233.29
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.843.17
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.17237.78
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.144.36
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.144.36
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.851.03
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.879239.86
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.879239.86
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.638.6
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.737.78
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.336.49
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.423.46
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.422.58
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.527.54
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.721.19
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.6910522.48
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.117.41
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460614.65
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.116.96
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125232.33
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.244.29
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20238.95
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.9223939.51
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.839.58
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.539.58
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.139.58
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.354.47
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522548.21
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.244.21
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.661.38
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.147.51
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.835.69
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.237.37
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.223.07
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.120.77
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.221.14
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.58.81
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.922.64
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.920.3
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.426.32
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.820.46
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.419.73
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.937.85
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.840.07
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.341.14
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.441.07
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.642
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.448.13
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.939.58
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.449042.95
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.231.21
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018846.19
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.945.04
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.358.26
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.970.28
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.970.28
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.170.28
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.170.28
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.867.51
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.767.51
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.967.51
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.667.51
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.979.29
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.679.29
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.5079.29
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.679.29
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.879.29
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.979.29
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.467.21
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.570.39
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.260.91
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.461.95
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.152.02
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.952.02
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.352.02
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.352.02
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.352.02
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.251.44
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.253.62
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.953.62
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.453.54
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.153.62
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.453.62
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.252.86
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.341.57
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.149.89
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.249.89
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.749.89
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.541549.89
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.54149.89
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.652.27
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.652.27
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.25174852.27
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.752.27
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.652.27
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.453.37
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.846.49
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.928.78
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.528.78
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.228.78
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.128.78
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.726.49
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.434.9
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.934.9
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.134.9
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.334.9
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.797.79Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.297.79Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.297.79Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.8131.58Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.2131.58Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK